Yahoo Web Search

Sign In

Search results

  1. www.gilead.comGilead Sciences, Inc.

    Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

    • Careers at Gilead

      Equal Opportunities . As an equal opportunity employer,...

    • Medicines

      Gilead is committed to helping improve the lives of people...

    • Pipeline

      We have the strongest and most diversified pipeline in our...

    • U.S. Locations

      The Gilead office in Miami, Fla., is home to members of the...

    • Contact Us

      For Kite Medical Information, Clinical Trial Inquiries,...

    • Newsroom

      Access and Health Equity. Gilead Benefit Helps Employees...

    • Leadership

      The Gilead Leadership Team and Board of Directors provide...

    • Our Company

      At Gilead, we set – and achieve – bold ambitions to create a...

  2. ph.linkedin.com › company › gilead-sciencesGilead Sciences | LinkedIn - LinkedIn Philippines

    Gilead Sciences | 564,119 (na) tagasubaybay sa LinkedIn. Creating Possible | The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet. For more than 30...

  3. www.manilatimes.net › 2022/11/02 › newsGilead partners with UP Manila | The Manila Times

    Nov 2, 2022 · BIOTECHNOLOGY company Gilead Sciences teamed up with the Partnership for Health Advancement in Vietnam (HAIVN) to address barriers that limit diagnosis for hepatitis B and C and care in primary health care facilities in Vietnam and in the Philippines.

  4. www.gilead.com › news-and-press › press-roomGilead Joins First-of-its-Kind Public-Private ... - Gilead...

    Sep 22, 2022 · This multi-year initiative will have a phased approach to help address barriers that limit viral hepatitis diagnosis and care at primary healthcare facilities in Vietnam and the Philippines, two countries with high burdens of hepatitis B and C.

  5. www.gmanetwork.com › news › scitechGilead details promising early COVID antiviral data, setting up...

    Apr 5, 2023 · Gilead Sciences Inc on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials of the drug that have begun enrolling patients.

  6. www.gileadzeroingin.com › global-programs › philippinesPhilippines | Zeroing In

    Learn more about the organizations in Philippines receiving funding through Gilead’s corporative giving initiative, Zeroing In: Ending the HIV Epidemic.

  7. www.rappler.com › business › gilead-sciences-earnings-report-qGilead Sciences reports almost $900 million in Q3 2020 ... -...

    Oct 29, 2020 · Gilead Sciences' revenues jump 17% to $6.6 billion in the 3rd quarter of 2020, with a boost from remdesivir, which is used to treat COVID-19.